| Kimia Biosciences Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 530313 |
NSE Symbol : - |
P/E(TTM) : 18.87 |
|
ISIN Demat : INE285U01025 |
Div & Yield% : 0.00 |
EPS(TTM) : 1.73 |
|
Book Value(₹) : 2.45 |
Market Cap(₹Cr) : 154.43 |
Face Value(₹) : 1.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 34.00 | 23.58 | 38.24 | 30.10 | 28.18 | 22.40 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 34.00 | 23.58 | 38.24 | 30.10 | 28.18 | 22.40 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | -0.33 | 0.85 | 0.44 | 0.42 | 0.37 | 0.08 |
| Total Income | 33.67 | 24.43 | 38.69 | 30.52 | 28.55 | 22.48 |
| Total Expenditure | 31.48 | 21.06 | 30.06 | 25.10 | 24.81 | 18.69 |
| PBIDT | 2.19 | 3.37 | 8.62 | 5.42 | 3.74 | 3.79 |
| Interest | 0.27 | 1.75 | 1.40 | 1.01 | 1.04 | 1.11 |
| PBDT | 1.92 | 1.63 | 7.22 | 4.41 | 2.70 | 2.68 |
| Depreciation | 0.97 | 0.94 | 0.88 | 0.82 | 0.79 | 0.90 |
| Tax | 0.00 | 0.00 | 0.00 | -0.62 | 0.32 | 0.30 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.07 | 0.09 | 4.35 | -0.36 | -0.02 | 0.05 |
| Reported Profit After Tax | 1.02 | 0.60 | 1.99 | 4.57 | 1.61 | 1.44 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 1.02 | 0.60 | 1.99 | 4.57 | 1.61 | 1.44 |
| EPS (Unit Curr.) | 0.21 | 0.13 | 0.42 | 0.97 | 0.34 | 0.30 |
| EPS (Adj) (Unit Curr.) | 0.21 | 0.13 | 0.42 | 0.97 | 0.34 | 0.30 |
| Calculated EPS (Unit Curr.) | 0.21 | 0.13 | 0.42 | 0.97 | 0.34 | 0.30 |
| Calculated EPS (Adj) (Unit Curr.) | 0.21 | 0.13 | 0.42 | 0.97 | 0.34 | 0.30 |
| Calculated EPS (Ann.) (Unit Curr.) | 0.86 | 0.51 | 1.68 | 3.86 | 1.36 | 1.21 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 0.86 | 0.51 | 1.68 | 3.86 | 1.36 | 1.21 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 4.73 | 4.73 | 4.73 | 4.73 | 4.73 | 4.73 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 6.44 | 14.29 | 22.54 | 18.01 | 13.27 | 16.92 |
| PBDTM(%) | 5.65 | 6.91 | 18.88 | 14.65 | 9.58 | 11.96 |
| PATM(%) | 3.00 | 2.54 | 5.20 | 15.18 | 5.71 | 6.43 |